Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvir is a research paper published in Journal of Antimicrobial Chemotherapy (2020). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Gilead Sciences, Inc
Grant: IN-US-337-4310
National Institute on Drug Abuse at the National Institutes of Health
Grant: R01DA040499
NIH/NCATS Colorado CTSA
Grant: UL1 TR002535
National Institutes of Health
Grant: 3UL1TR002535-03S1
NIH Prior Approval Process Professional
National Institutes of Health
Grant: 5R01DA040499-05
Antiviral pharmacology and adherence in drug users
FWCI
0.22
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals